Need a specific person's email?
Browse Actinium Pharmaceuticals, Inc.'s employee directory (about 56 employees) and reveal verified emails free.
Actinium Pharmaceuticals, Inc.'s most common email format is FLast@actiniumpharma.com (ex. JDoe@actiniumpharma.com), used for 73% of actiniumpharma.com addresses. Actinium Pharmaceuticals, Inc. uses 4 email patterns.
| Format | Example | Share of actiniumpharma.com |
|---|---|---|
| FLast@actiniumpharma.comMost common | JDoe@actiniumpharma.com | |
| First.Last@actiniumpharma.com | John.Doe@actiniumpharma.com | |
| Last@actiniumpharma.com | Doe@actiniumpharma.com | |
| FMiddleLast@actiniumpharma.com | JMichaelDoe@actiniumpharma.com |
Browse Actinium Pharmaceuticals, Inc.'s employee directory (about 56 employees) and reveal verified emails free.
Biotechnology ResearchNew York, United States51-200 Employees
Actinium Pharmaceuticals is a biotechnology company focused on targeted radiotherapies for cancer. Based in New York, New York, it develops radiopharmaceuticals for solid tumors and hematologic malignancies using a biology-driven approach that integrates tumor biology, translational medicine, and radiochemistry. Its pipeline covers solid-tumor therapeutics (ATNM-400 and Actimab-A with pan-tumor potential), Actimab-A as a backbone for AML and MDS in collaboration with the National Cancer Institute, and targeted conditioning agents such as Iomab-B and Iomab-ACT. ATNM-400 targets a novel antigen distinct from PSMA and has shown preclinical activity in metastatic castration-resistant prostate cancer, non-small cell lung cancer, and breast cancer. Recent activity includes updates on ATNM-400 at the SNMMI 2026 Annual Meeting in May 2026.
Most common format
FLast@actiniumpharma.com
Example: JDoe@actiniumpharma.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.